血小板功能检测指导下的双联抗血小板治疗 - Suppr

Suppr

超能文献

Dual antiplatelet therapy guided by platelet function testing.

作者信息

Angiolillo Dominick J

机构信息

University of Florida College of Medicine-Jacksonville, Jacksonville, FL 32209, USA.

出版信息

Lancet. 2017 Oct 14;390(10104):1718-1720. doi: 10.1016/S0140-6736(17)32279-1. Epub 2017 Aug 28.

DOI:10.1016/S0140-6736(17)32279-1

PMID:28855079

Abstract

摘要

相似文献

Dual antiplatelet therapy guided by platelet function testing.血小板功能检测指导下的双联抗血小板治疗

Lancet. 2017 Oct 14;390(10104):1718-1720. doi: 10.1016/S0140-6736(17)32279-1. Epub 2017 Aug 28.

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial.经皮冠状动脉介入治疗的急性冠状动脉综合征患者的抗血小板治疗降级指导（TROPICAL-ACS）：一项随机、开放标签、多中心试验。

Lancet. 2017 Oct 14;390(10104):1747-1757. doi: 10.1016/S0140-6736(17)32155-4. Epub 2017 Aug 28.

How to select antiplatelet therapy in patients with acute coronary syndrome, according to platelet function testing or pharmacogenomic testing?如何根据血小板功能检测或药物基因组学检测为急性冠脉综合征患者选择抗血小板治疗？

Int J Cardiol. 2018 Nov 15;271:28. doi: 10.1016/j.ijcard.2018.05.121.

A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.一项关于接受经皮冠状动脉介入治疗（PCI）的急性冠状动脉综合征（ACS）患者血小板功能引导下抗血小板治疗降阶梯的随机试验。急性冠状动脉综合征慢性抗血小板治疗中血小板抑制反应性测试（TROPICAL-ACS）试验的原理与设计。

Thromb Haemost. 2017 Jan 5;117(1):188-195. doi: 10.1160/TH16-07-0557. Epub 2016 Sep 22.

Individualized dual antiplatelet therapy based on platelet function testing in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials.经皮冠状动脉介入治疗患者基于血小板功能检测的个体化双联抗血小板治疗：随机对照试验的荟萃分析

BMC Cardiovasc Disord. 2017 Jun 15;17(1):157. doi: 10.1186/s12872-017-0582-6.

Current Role of Platelet Function Testing in Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting.血小板功能检测在经皮冠状动脉介入治疗和冠状动脉旁路移植术中的当前作用

Interv Cardiol Clin. 2017 Jan;6(1):151-166. doi: 10.1016/j.iccl.2016.08.011.

New antiplatelet agents and the role of platelet function testing in acute coronary syndromes.新型抗血小板药物与血小板功能检测在急性冠脉综合征中的作用。

Clin Ther. 2013 Aug;35(8):1064-8. doi: 10.1016/j.clinthera.2013.07.429.

Guided de-escalation of DAPT in acute coronary syndrome patients undergoing percutaneous coronary intervention with BVS implantation: a post-hoc analysis from the randomized TROPICAL-ACS trial.指导急性冠状动脉综合征患者经皮冠状动脉介入治疗伴生物可吸收支架植入术后的 DAPT 降级：随机 TROPICAL-ACS 试验的事后分析。

J Thromb Thrombolysis. 2019 Apr;47(3):427-435. doi: 10.1007/s11239-019-01811-2.

Diabetes and outcomes following guided de-escalation of antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: a pre-specified analysis from the randomised TROPICAL-ACS trial.糖尿病患者行经皮冠状动脉介入治疗的急性冠状动脉综合征患者抗血小板治疗降级指导后的结局：来自随机 TROPICAL-ACS 试验的预先指定分析。

EuroIntervention. 2019 Aug 9;15(6):e513-e521. doi: 10.4244/EIJ-D-18-01077.

Efficacy of ex vivo autologous and in vivo platelet transfusion in the reversal of P2Y12 inhibition by clopidogrel, prasugrel, and ticagrelor: the APTITUDE study.体外自体和体内血小板输注逆转氯吡格雷、普拉格雷和替格瑞洛对P2Y12抑制作用的疗效：APTITUDE研究

Circ Cardiovasc Interv. 2015 Nov;8(11):e002786. doi: 10.1161/CIRCINTERVENTIONS.115.002786.

引用本文的文献

Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes.急性冠状动脉综合征的抗血小板治疗指导策略。

Int J Mol Sci. 2024 Apr 3;25(7):3981. doi: 10.3390/ijms25073981.

Guided vs. conventional anti-platelet therapy for patients with acute coronary syndrome: A meta-analysis of randomized controlled trials.急性冠状动脉综合征患者的指导性抗血小板治疗与传统抗血小板治疗：一项随机对照试验的荟萃分析。

Front Cardiovasc Med. 2023 Mar 21;10:1079332. doi: 10.3389/fcvm.2023.1079332. eCollection 2023.

De-escalation of antiplatelet therapy in acute coronary syndromes: Why, how and when?急性冠状动脉综合征中抗血小板治疗的降阶梯：为何、如何以及何时？

Front Cardiovasc Med. 2022 Aug 25;9:975969. doi: 10.3389/fcvm.2022.975969. eCollection 2022.

Antiplatelet therapy after percutaneous coronary intervention.经皮冠状动脉介入治疗后的抗血小板治疗。

EuroIntervention. 2022 Apr 1;17(17):e1371-e1396. doi: 10.4244/EIJ-D-21-00904.

Genetic testing in patients undergoing percutaneous coronary intervention: rationale, evidence and practical recommendations.经皮冠状动脉介入治疗患者的基因检测：原理、证据和实用建议。

Expert Rev Clin Pharmacol. 2021 Aug;14(8):963-978. doi: 10.1080/17512433.2021.1927709. Epub 2021 May 26.

High glycated albumin is an independent predictor of low response to clopidogrel in ACS patients: a cross-sectional study.糖化白蛋白水平高是 ACS 患者对氯吡格雷低反应的独立预测因子：一项横断面研究。

Cardiovasc Diabetol. 2020 Oct 9;19(1):171. doi: 10.1186/s12933-020-01146-w.

Point-of-care platelet function tests: relevance to arterial thrombosis and opportunities for improvement.即时血小板功能检测：与动脉血栓形成的相关性及改进机会。

J Thromb Thrombolysis. 2021 Jan;51(1):1-11. doi: 10.1007/s11239-020-02170-z.

De-escalation therapy after acute coronary syndrome: is it reasonable to switch from prasugrel (or ticagrelor) to clopidogrel early?急性冠状动脉综合征后的降阶梯治疗：早期从普拉格雷（或替格瑞洛）转换为氯吡格雷是否合理？

Eur Heart J Suppl. 2020 Jun;22(Suppl E):E132-E136. doi: 10.1093/eurheartj/suaa078. Epub 2020 Mar 29.

Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-Function Genotypes: Results of a Randomized Pharmacodynamic Study in a Feasibility Investigation of Rapid Genetic Testing.携带CYP2C19功能缺失基因型患者中普拉格雷与替格瑞洛的比较：快速基因检测可行性研究中的一项随机药效学研究结果

JACC Basic Transl Sci. 2020 Mar 25;5(5):419-428. doi: 10.1016/j.jacbts.2020.02.009. eCollection 2020 May.

[Platelet GPⅠb-Ⅸ-Ⅴ receptor-mediated mechanism and its application in thrombotic diseases].[血小板糖蛋白Ⅰb-Ⅸ-Ⅴ受体介导机制及其在血栓性疾病中的应用]

Zhonghua Xue Ye Xue Za Zhi. 2019 Jun 14;40(6):532-536. doi: 10.3760/cma.j.issn.0253-2727.2019.06.017.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验